The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reducing Hypoglycemia Fear in Parents of Young Children With Type 1 Diabetes (REDCHiP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03879642
Recruitment Status : Completed
First Posted : March 19, 2019
Results First Posted : January 14, 2022
Last Update Posted : January 25, 2022
Sponsor:
Collaborator:
Children's Mercy Hospital Kansas City
Information provided by (Responsible Party):
University of Kansas Medical Center

Study Type Interventional
Study Design Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: None (Open Label);   Primary Purpose: Prevention
Condition Parents
Intervention Behavioral: REDCHiP
Enrollment 43
Recruitment Details recruitment in clinic and by telephone
Pre-assignment Details the study over-recruited the original study protocol by 3 parents; pre-assignment, parents completed baseline assessment measures;
Arm/Group Title REDCHiP Waitlist
Hide Arm/Group Description

10 week video-based telemedicine intervention to reduce parents hypoglycemia fear

REDCHiP: 10 week video-based telemedicine intervention to reduce hypoglycemia fear

10 week no intervention to provide waitlist control condition
Period Title: Overall Study
Started 22 21
Completed 19 18
Not Completed 3 3
Arm/Group Title REDCHiP Waitlist Total
Hide Arm/Group Description

10 week video-based telemedicine intervention to reduce parents hypoglycemia fear

REDCHiP: 10 week video-based telemedicine intervention to reduce hypoglycemia fear

10 week no intervention to provide waitlist control condition Total of all reporting groups
Overall Number of Baseline Participants 22 21 43
Hide Baseline Analysis Population Description
[Not Specified]
Age, Categorical  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 22 participants 21 participants 43 participants
<=18 years
0
   0.0%
0
   0.0%
0
   0.0%
Between 18 and 65 years
22
 100.0%
21
 100.0%
43
 100.0%
>=65 years
0
   0.0%
0
   0.0%
0
   0.0%
Age, Continuous   [1] 
Mean (Standard Deviation)
Unit of measure:  Years
Number Analyzed 21 participants 20 participants 41 participants
33.81  (4.59) 36.75  (5.02) 36.0  (4.9)
[1]
Measure Analysis Population Description: one parent from each condition did not complete all the baseline assessment measures
Sex: Female, Male   [1] 
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 21 participants 20 participants 41 participants
Female
21
 100.0%
19
  95.0%
40
  97.6%
Male
0
   0.0%
1
   5.0%
1
   2.4%
[1]
Measure Analysis Population Description: one parent from each condition did not complete all baseline assessments
Ethnicity (NIH/OMB)   [1] 
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 22 participants 20 participants 42 participants
Hispanic or Latino
1
   4.5%
1
   5.0%
2
   4.8%
Not Hispanic or Latino
21
  95.5%
17
  85.0%
38
  90.5%
Unknown or Not Reported
0
   0.0%
2
  10.0%
2
   4.8%
[1]
Measure Analysis Population Description: one parent in the waitlist control group did not complete this survey
Race (NIH/OMB)  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 22 participants 21 participants 43 participants
American Indian or Alaska Native
0
   0.0%
0
   0.0%
0
   0.0%
Asian
0
   0.0%
0
   0.0%
0
   0.0%
Native Hawaiian or Other Pacific Islander
0
   0.0%
0
   0.0%
0
   0.0%
Black or African American
0
   0.0%
1
   4.8%
1
   2.3%
White
21
  95.5%
19
  90.5%
40
  93.0%
More than one race
1
   4.5%
0
   0.0%
1
   2.3%
Unknown or Not Reported
0
   0.0%
1
   4.8%
1
   2.3%
1.Primary Outcome
Title Hypoglycemia Fear Survey
Hide Description Hypoglycemia Fear Survey-Parents of Young Children. This is a measure of parents' perceived hypoglycemia fear. Higher scores suggest greater fear (worse outcome). Total possible range: 26-130.
Time Frame absolute value at post-treatment (week 14)
Hide Outcome Measure Data
Hide Analysis Population Description
43 parents enrolled and were randomized; 36 parents completed the treatment. Therefore number analyzed reflects 36 parents who completed treatment.
Arm/Group Title REDCHiP Waitlist
Hide Arm/Group Description:

10 week video-based telemedicine intervention to reduce parents hypoglycemia fear

REDCHiP: 10 week video-based telemedicine intervention to reduce hypoglycemia fear

10 week no intervention to provide waitlist control condition
Overall Number of Participants Analyzed 18 18
Mean (Standard Deviation)
Unit of Measure: units on a scale
75.94  (18.46) 70.78  (14.93)
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection REDCHiP, Waitlist
Comments [Not Specified]
Type of Statistical Test Superiority
Comments [Not Specified]
Statistical Test of Hypothesis P-Value [Not Specified]
Comments [Not Specified]
Method ANOVA
Comments [Not Specified]
Method of Estimation Estimation Parameter partial eta squared
Estimated Value .117
Estimation Comments [Not Specified]
2.Secondary Outcome
Title Child Hemoglobin A1c
Hide Description Child hemoglobin A1c- biological marker of glycemic control
Time Frame absolute value at post-treatment (week 14)
Hide Outcome Measure Data
Hide Analysis Population Description
43 parents enrolled and were randomized; 36 parents completed the treatment. Therefore number analyzed reflects 36 parents who completed treatment.
Arm/Group Title REDCHiP Waitlist
Hide Arm/Group Description:

10 week video-based telemedicine intervention to reduce parents hypoglycemia fear

REDCHiP: 10 week video-based telemedicine intervention to reduce hypoglycemia fear

10 week no intervention to provide waitlist control condition
Overall Number of Participants Analyzed 18 18
Mean (Standard Deviation)
Unit of Measure: percentage of glycated hemoglobin cells
8.07  (1.30) 7.97  (0.80)
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection REDCHiP, Waitlist
Comments [Not Specified]
Type of Statistical Test Superiority
Comments [Not Specified]
Statistical Test of Hypothesis P-Value [Not Specified]
Comments [Not Specified]
Method repeated measures ANOVA
Comments [Not Specified]
Method of Estimation Estimation Parameter partial eta squared
Estimated Value .005
Estimation Comments [Not Specified]
Time Frame through study completion, average 7 months
Adverse Event Reporting Description Adverse event = episodes of prolong low blood glucose value (>1 hour); increase in frequency of any low blood glucose events (glucose <70 mg/dl)
 
Arm/Group Title REDCHiP Waitlist
Hide Arm/Group Description

10 week video-based telemedicine intervention to reduce parents hypoglycemia fear

REDCHiP: 10 week video-based telemedicine intervention to reduce hypoglycemia fear

10 week no intervention to provide waitlist control condition
All-Cause Mortality
REDCHiP Waitlist
Affected / at Risk (%) Affected / at Risk (%)
Total   0/22 (0.00%)   0/21 (0.00%) 
Hide Serious Adverse Events
REDCHiP Waitlist
Affected / at Risk (%) Affected / at Risk (%)
Total   0/22 (0.00%)   0/21 (0.00%) 
Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
REDCHiP Waitlist
Affected / at Risk (%) Affected / at Risk (%)
Total   0/22 (0.00%)   0/21 (0.00%) 
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Dr. Susana Patton
Organization: Nemours Children's Health-Jacksonville
Phone: 904-697-2000
EMail: susana.patton@nemours.org
Layout table for additonal information
Responsible Party: University of Kansas Medical Center
ClinicalTrials.gov Identifier: NCT03879642    
Other Study ID Numbers: R21HD081502 ( U.S. NIH Grant/Contract )
First Submitted: March 11, 2019
First Posted: March 19, 2019
Results First Submitted: October 14, 2021
Results First Posted: January 14, 2022
Last Update Posted: January 25, 2022